(Unless otherwise stated, all abbreviations and definitions used herein shall have the same meaning as those used in the Company's announcements dated 13 April 2018 and 16 May2018 in relation to the Proposed Acquisition)

The Board of Directors of CCM Duopharma Biotech Berhad("CCM Duopharma") wishes to announce that the shareholders of CCM Duopharmahave approved the ordinary resolution relating to the Proposed Acquisitionas set out in the Notice of Extraordinary General Meeting("EGM") dated 16 May2018 at the EGM held earlier today.

The voting in respect of the ordinary resolution was carried out by way of poll and the result was validated by Asia Securities Sdn Berhad, the independent scrutineer appointed by CCM Duopharma.

Please refer to the Appendix 1 for the results of the poll.

This Announcement is dated 31 May2018.